HCA Healthcare Inc (HCA) PT Lowered to $485 at Goldman Sachs

July 28, 2026 6:37 AM

Goldman Sachs analyst Scott Fidel lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $485.00 (from $558.00) while maintaining a Buy rating.

No results found